Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
YX3ch23Sc4sK9p0n
Écouter
Français